Micrococcus luteus (Schroeter) Cohn (ATCC® 10240)

Strain Designations: 130.21 [ATCC 10786]  /  Type Strain: no  /  Biosafety Level: 1

Deposited As Micrococcus flavus Trevisan
Strain Designations 130.21 [ATCC 10786]
Application
Assay of bacitracin
Quality control strain
Food testing
Pharmaceutical and Personal Care
Isolation
Air
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Medium ATCC® Medium 3: Nutrient agar or nutrient broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor Commercial Solvents Corp.
Chain of Custody
ATCC <-- Commercial Solvents Corp. <-- AR Stanley
Isolation
Air
References

British Pharmacopoeia Commission Biological assay of antibiotics. London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XIV A, 2003

AOAC International Bacitracin-MD (BMD) in complete feed, microbiological plate assay method. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 993.29.

European Pharmacopoeia Commission Microbiological assay of antibiotics. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.7.2, 1997

U.S. Pharmacopeia General Chapters; <81> Antibiotics-Microbial Assays. Rockville, MD: U.S. Pharmacopeia; USP USP34-NF29, 2011

AOAC International Antibiotics in feeds, microbiological methods. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 957.23.

AOAC International Bacitracin in premix feeds. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 982.43.

Applied Biosystems, MicroSeq Pharmaceutical Validation Panel.

Microbial assay for antibiotics. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.34.